Your browser doesn't support javascript.
loading
Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period.
Korotkov, Anatoly; Luinenburg, Mark J; Romagnolo, Alessia; Zimmer, Till S; van Scheppingen, Jackelien; Bongaarts, Anika; Broekaart, Diede W M; Anink, Jasper J; Mijnsbergen, Caroline; Jansen, Floor E; van Hecke, Wim; Spliet, Wim G; van Rijen, Peter C; Feucht, Martha; Hainfellner, Johannes A; Krsek, Pavel; Zamecnik, Josef; Crino, Peter B; Kotulska, Katarzyna; Lagae, Lieven; Jansen, Anna C; Kwiatkowski, David J; Jozwiak, Sergiusz; Curatolo, Paolo; Mühlebner, Angelika; van Vliet, Erwin A; Mills, James D; Aronica, Eleonora.
Afiliação
  • Korotkov A; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Luinenburg MJ; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Romagnolo A; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Zimmer TS; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • van Scheppingen J; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Bongaarts A; Department of Neuroimmunology, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands.
  • Broekaart DWM; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Anink JJ; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Mijnsbergen C; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Jansen FE; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • van Hecke W; Department of Paediatric Neurology, University Medical Center, Brain Center, Utrecht, the Netherlands.
  • Spliet WG; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Rijen PC; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Feucht M; Rudolf Magnus Institute for Neuroscience, University Medical Center, Brain Center, Utrecht, the Netherlands.
  • Hainfellner JA; Department of Pediatrics, Medical University Vienna, Vienna, Austria.
  • Krsek P; Institute of Neurology, Medical University Vienna, Vienna, Austria.
  • Zamecnik J; Department of Pediatric Neurology, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
  • Crino PB; Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
  • Kotulska K; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Lagae L; Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
  • Jansen AC; Department of Development and Regeneration-Section Pediatric Neurology, University Hospitals KU Leuven, Leuven, Belgium.
  • Kwiatkowski DJ; Pediatric Neurology Unit, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Jozwiak S; Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Curatolo P; Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Mühlebner A; Department of Clinical and Experimental Epilepsy, University College London, London, UK.
  • van Vliet EA; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Mills JD; Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Aronica E; Center for Neuroscience, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, the Netherlands.
J Neurodev Disord ; 14(1): 8, 2022 01 15.
Article em En | MEDLINE | ID: mdl-35030990
ABSTRACT

BACKGROUND:

The genetic disorder tuberous sclerosis complex (TSC) is frequently accompanied by the development of neuropsychiatric disorders, including autism spectrum disorder and intellectual disability, with varying degrees of impairment. These co-morbidities in TSC have been linked to the structural brain abnormalities, such as cortical tubers, and recurrent epileptic seizures (in 70-80% cases). Previous transcriptomic analysis of cortical tubers revealed dysregulation of genes involved in cell adhesion in the brain, which may be associated with the neurodevelopmental deficits in TSC. In this study we aimed to investigate the expression of one of these genes - cell-adhesion molecule contactin-3.

METHODS:

Reverse transcription quantitative polymerase chain reaction for the contactin-3 gene (CNTN3) was performed in resected cortical tubers from TSC patients with drug-resistant epilepsy (n = 35, age range 1-48 years) and compared to autopsy-derived cortical control tissue (n = 27, age range 0-44 years), as well as by western blot analysis of contactin-3 (n = 7 vs n = 7, age range 0-3 years for both TSC and controls) and immunohistochemistry (n = 5 TSC vs n = 4 controls). The expression of contactin-3 was further analyzed in fetal and postnatal control tissue by western blotting and in-situ hybridization, as well as in the SH-SY5Y neuroblastoma cell line differentiation model in vitro.

RESULTS:

CNTN3 gene expression was lower in cortical tubers from patients across a wide range of ages (fold change = - 0.5, p < 0.001) as compared to controls. Contactin-3 protein expression was lower in the age range of 0-3 years old (fold change = - 3.8, p < 0.001) as compared to the age-matched controls. In control brain tissue, contactin-3 gene and protein expression could be detected during fetal development, peaked around birth and during infancy and declined in the adult brain. CNTN3 expression was induced in the differentiated SH-SY5Y neuroblastoma cells in vitro (fold change = 6.2, p < 0.01).

CONCLUSIONS:

Our data show a lower expression of contactin-3 in cortical tubers of TSC patients during early postnatal period as compared to controls, which may affect normal brain development and might contribute to neuropsychiatric co-morbidities observed in patients with TSC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Tuberosa / Contactinas Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Tuberosa / Contactinas Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article